Personalised medicine outsourcing market to reach $223.69b by 2030

One key driver is the need for specialised expertise.

The global personalised medicine outsourcing market is projected to reach $223.69b by 2030 at a compound annual growth rate of 12.47%, according to Research and Markets.

The sector’s expansion is attributed to the rising awareness about personalised medicine, increasing application across various diseases, a need for specialised expertise, and the benefits of outsourcing services.

“CROs and CDMOs have witnessed significant growth during the past few years as most of the pharmaceutical companies are opting to outsource their drug development and manufacturing activities,” the report said.

Moreover, personalised medicine is increasingly utilised to treat rare diseases, cancer, and infectious diseases.